Prestige BioPharma Limited (KRX:950210)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,270
0.00 (0.00%)
At close: Jun 5, 2025, 3:30 PM KST

Prestige BioPharma Cash Flow Statement

Millions KRW. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Mar '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2019
Net Income
21,788-32,92117,569-211,450-7,391-14,997
Upgrade
Depreciation & Amortization
16,26716,26711,6503,8671,6671,185
Upgrade
Loss (Gain) From Sale of Assets
-89.4-89.4-55.17-266.370.36-
Upgrade
Asset Writedown & Restructuring Costs
--15,11472,607--
Upgrade
Loss (Gain) From Sale of Investments
--693.3918,966-15,081599.83
Upgrade
Stock-Based Compensation
52.4152.411,9433,7742,955-
Upgrade
Provision & Write-off of Bad Debts
-33.31-33.31-70,640---
Upgrade
Other Operating Activities
-110,251-42,356-17,82685,640330.513,816
Upgrade
Change in Accounts Receivable
674.94674.94-1,050--2,021
Upgrade
Change in Inventory
7,7527,752-10,038-24,041--
Upgrade
Change in Accounts Payable
2,4592,459-316.41,641--
Upgrade
Change in Unearned Revenue
-5.21-5.21-660.52564.62578.1-1,674
Upgrade
Change in Other Net Operating Assets
172.41172.41-6,6582,7911,495-3,371
Upgrade
Operating Cash Flow
-61,213-48,027-60,274-45,907-15,446-12,421
Upgrade
Capital Expenditures
-37,753-20,063-48,363-56,429-949.11-1,340
Upgrade
Sale of Property, Plant & Equipment
72.8751.211,13326,428--
Upgrade
Divestitures
--40,039---
Upgrade
Sale (Purchase) of Intangibles
-2,604-7,463-17,254-11,684-17,162-17,393
Upgrade
Investment in Securities
-30,245159,987-133,827-25,239--
Upgrade
Other Investing Activities
-1,337-46.859,66212,555-2,801694.11
Upgrade
Investing Cash Flow
-71,867132,465-148,610-184,685-20,912-18,039
Upgrade
Long-Term Debt Issued
--55,772-2,7694,783
Upgrade
Long-Term Debt Repaid
--2,771-2,589-4,504-895.88-221.95
Upgrade
Net Debt Issued (Repaid)
51,786-2,77153,183-4,5041,8734,561
Upgrade
Issuance of Common Stock
-1,307--466,094-
Upgrade
Other Financing Activities
-----13,4500
Upgrade
Financing Cash Flow
51,781-1,46453,183-4,504454,51766,141
Upgrade
Foreign Exchange Rate Adjustments
1,670608.726,888-3,177-277.54-72.67
Upgrade
Miscellaneous Cash Flow Adjustments
-0-0000-
Upgrade
Net Cash Flow
-79,62983,582-148,813-238,273417,88035,608
Upgrade
Free Cash Flow
-98,966-68,091-108,636-102,336-16,396-13,761
Upgrade
Free Cash Flow Margin
-1142.47%-9881.47%-67125.45%---
Upgrade
Free Cash Flow Per Share
-1643.50-1133.03-1807.71-1702.88-317.73-322.63
Upgrade
Cash Interest Paid
10,7436,0821,834436.07477.47165.7
Upgrade
Cash Income Tax Paid
--179.73796.41591.8234.0898.47
Upgrade
Levered Free Cash Flow
-93,834-55,426-23,046-114,523-22,341-24,081
Upgrade
Unlevered Free Cash Flow
-89,206-50,799-22,451-114,511-22,337-24,081
Upgrade
Change in Net Working Capital
26,272694.59-28,875-22,642-2,642-1,525
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.